|
TOP2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.72690000369514E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.75140000000007E-05 |
| Normal-vs-Stage2 |
3.185500E-04 |
| Normal-vs-Stage3 |
2.17599999996487E-06 |
| Normal-vs-Stage4 |
4.14549999994129E-07 |
| Stage1-vs-Stage2 |
6.634400E-01 |
| Stage1-vs-Stage3 |
3.789700E-02 |
| Stage1-vs-Stage4 |
4.426100E-04 |
| Stage2-vs-Stage3 |
1.641560E-01 |
| Stage2-vs-Stage4 |
1.355410E-03 |
| Stage3-vs-Stage4 |
1.490110E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.86329999710233E-08 |
| Normal-vs-AfricanAmerican |
1.337710E-02 |
| Normal-vs-Asian |
1.264000E-01 |
| Caucasian-vs-AfricanAmerican |
1.538330E-03 |
| Caucasian-vs-Asian |
5.038400E-01 |
| AfricanAmerican-vs-Asian |
2.979400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.73790000063323E-08 |
| Normal-vs-Female |
2.99209999998773E-06 |
| Male-vs-Female |
8.245500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.968310E-04 |
| Normal-vs-Age(41-60Yrs) |
7.41629999967408E-07 |
| Normal-vs-Age(61-80Yrs) |
3.27319999993136E-07 |
| Normal-vs-Age(81-100Yrs) |
2.055800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.351400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.715800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.274300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.694000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.928400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.449900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.141700E-02 |
| Normal-vs-Grade 2 |
4.41669999999839E-05 |
| Normal-vs-Grade 3 |
4.01129999993977E-07 |
| Normal-vs-Grade 4 |
2.24650000002491E-06 |
| Grade 1-vs-Grade 2 |
1.487510E-02 |
| Grade 1-vs-Grade 3 |
4.039900E-04 |
| Grade 1-vs-Grade 4 |
1.029900E-04 |
| Grade 2-vs-Grade 3 |
5.474300E-02 |
| Grade 2-vs-Grade 4 |
1.360360E-03 |
| Grade 3-vs-Grade 4 |
8.277000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.759720E-04 |
| Normal-vs-ccB subtype |
6.78129999931443E-08 |
| ccA subtype-vs-ccB subtype |
1.197370E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.7573000005443E-07 |
| Normal-vs-N1 |
7.832400E-04 |
| N0-vs-N1 |
1.785900E-02 |
|
|
